SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Booms, Busts, and Recoveries

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NOW who wrote (60597)2/25/2005 2:41:33 PM
From: Elroy Jetson  Read Replies (1) of 74559
 
Based on cause and effect.

Unless a pathogen kills by inducing a hyper-immune or auto-immune response, engaging the immune system is usually the route to controlling the pathogen. At one time much of medicine was based on immune augmentation, until the success of chemotherapies like antibitotics made research into the human immune system seem unimportant.

When the immune system loses a fight, it is usually due to the head-start the pathogen gains before the immune system recognizes and responds to the pathogen.

Reducing the delay in immune response to H5N1 avian influenza is the basis for both vaccination and interferon-alpha.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext